ライフサイエンスコーパス: manic-depressive

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 Times to symptomatic relapse into manic, depressive, and mixed episodes were all significa

2 comes investigated included risk of relapse (manic, depressive, and total) as well as risk of specifi

3 was organized by the National Depressive and Manic Depressive Association (NDMDA) on January 17-18, 1

4 Nevertheless, true to its manic-depressive behavior, new evidence links TGF-beta w

5 1.05-3.64; P = .03; AR, 6.9/10,000 persons), manic-depressive disorder (HR, 4.35; 95% CI, 1.56-12.09;

6 sk of suicide included male sex, depression, manic-depressive disorder, heavy or binge drinking, and

7 dy the normal brain, encephalitis, epilepsy, manic-depressive disorder, schizophrenia and brain tumor

8 ffective drugs for the treatment of bipolar (manic-depressive) disorder, also has dramatic effects on

9 most widely used drugs for treating bipolar (manic-depressive) disorder.

10 factors in the etiology of such disorders as manic depressive illness and schizophrenia.

11 Manic depressive illness is a common and frequently debi

12 Bipolar disorder or manic depressive illness is a major psychiatric disorder

13 Using such methods, linkage of manic depressive illness to loci on chromosome 18 has be

14 such psychiatric diseases as schizophrenia, manic depressive illness, and borderline personality dis

15 Manic depressive illness, or bipolar disorder (BP), is c

16 most commonly used drug for the treatment of manic depressive illness.

17 e "insanity" similar to dementia praecox and manic depressive illness.

18 s its clinical efficacy in the treatment for manic depressive illness.

19 lly and genetically complex disorder such as manic depressive illness.

20 underlying lithium's therapeutic efficacy in manic-depressive illness (bipolar affective disorder) is

21 ing which our major diagnostic categories of manic-depressive illness (MDI) and dementia praecox were

22 Manic-depressive illness afflicts about one percent of t

23 athophysiology and therapeutic mechanisms of manic-depressive illness are unknown.

24 Manic-depressive illness has been conceptualized as a ne

25 emical action of lithium in the treatment of manic-depressive illness is still unknown.

26 stic features of bipolar affective disorder (manic-depressive illness) are episodes of mania (bipolar

27 Bipolar affective disorder (manic-depressive illness) is a chronic, severe, debilita

28 Bipolar affective disorder (BPAD; manic-depressive illness) is characterized by episodes o

29 ood modulation, molecular pathophysiology of manic-depressive illness, and therapeutic mechanism of m

30 y used mood stabilizers for the treatment of manic-depressive illness, stimulated the ERK pathway in

31 rebral morphometric deficits associated with manic-depressive illness.

32 s in the right frontal lobe of patients with manic-depressive illness.

33 udinally in 12 adult depressed patients with manic-depressive illness.

34 sis for the therapeutic action of lithium in manic-depressive illness.

35 ne of the proposed targets of Li+ therapy in manic-depressive illness.

36 n psychiatric nosology that contained DP and manic-depressive insanity (MDI)--Kraepelin's key categor

37 lin's new categories of dementia praecox and manic-depressive insanity were too broad and too heterog

38 Manic-depressive patients with diabetes mellitus have a

39 trophy and loss in discrete brain regions of manic-depressive patients.

40 gets for lithium therapy in the treatment of manic-depressive patients.

41 psychopharmacological effects on ameliorate manic-depressive psychosis.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。